Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMPH Amphastar Pharmaceuticals

盘后交易 10-02 16:36:10 EDT

25.43

+0.08

+0.32%

盘后25.43

+0.000.00%

16:15 EDT

最高25.55	最低25.06	成交量37.23万
今开25.46	昨收25.35	日振幅1.91%
总市值10.82亿	流通市值7.76亿	总股本4,254万
成交额943.89万	换手率1.22%	流通股本3,052万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMPH","market":"US","secType":"STK","nameCN":"Amphastar Pharmaceuticals","latestPrice":25.43,"timestamp":1790971200000,"preClose":25.35,"halted":0,"volume":372329,"hourTrading":{"tag":"盘后","latestPrice":25.43,"preClose":25.43,"latestTime":"16:15 EDT","volume":39746,"amount":1010740.78,"timestamp":1790972100268,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0031558185404338577,"floatShares":30520135,"shares":42537944,"eps":1.686947,"marketStatus":"盘后交易","change":0.08,"latestTime":"10-02 16:36:10 EDT","open":25.46,"high":25.545,"low":25.06,"amount":9438862,"amplitude":0.019132,"askPrice":25.93,"askSize":77,"bidPrice":25,"bidSize":1,"shortable":3,"etf":0,"ttmEps":1.686947,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1403668800000,"exchange":"NASDAQ","adjPreClose":25.35,"postHourTrading":{"tag":"盘后","latestPrice":25.43,"preClose":25.43,"latestTime":"16:15 EDT","volume":39746,"amount":1010740.78,"timestamp":1790972100268,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.664619,"impliedVol":0.7835,"impliedVolPercentile":0.9084},"requestUrl":"/m/hq/s/AMPH","defaultTab":"news","newsList":[{"id":"1133818177","title":"特朗普药品关税计划引发关注：药价、药企与供应链将受何影响？","url":"https://stock-news.laohu8.com/highlight/detail?id=1133818177","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133818177?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:56","pubTimestamp":1784732210,"startTime":"0","endTime":"0","summary":"特朗普拟对进口仿制药实施最高200%的关税，引发市场对药价上涨、供应链重构及药企盈利的担忧。业内人士认为，两年缓冲期为企业调整产能提供了窗口，但政策细则仍待明确，最终影响将取决于关税实施范围及美国本土制造认定标准，不同药企面临的冲击或将明显分化。","market":"us","thumbnail":"https://static.tigerbbs.com/556186869d2b495debe9035461bacadc","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/556186869d2b495debe9035461bacadc"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"特朗普药品关税计划引发关注：药价、药企与供应链将受何影响？","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","ANIP","AMPH","TEVA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1197314104","title":"Amphastar Pharmaceuticals：美国FDA警告信不要求其子公司停产、限售或召回产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1197314104","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197314104?lang=zh_cn&edition=full","pubTime":"2026-07-08 18:08","pubTimestamp":1783505297,"startTime":"0","endTime":"0","summary":"根据Amphastar Pharmaceuticals向美国证券交易委员会（SEC）提交的文件显示，公司收到的一份美国食品药品监督管理局（FDA）警告信，并未要求其相关业务单元停止生产、限制销售或召回任何产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","AMPH","BK4007","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167020881","title":"美国FDA批准非处方鼻喷剂Rextovy，4毫克盐酸纳洛酮用于阿片类药物过量急救","url":"https://stock-news.laohu8.com/highlight/detail?id=1167020881","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167020881?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:49","pubTimestamp":1781614154,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已批准一款非处方（OTC）鼻内给药纳洛酮产品——Rextovy。该产品为4毫克盐酸纳洛酮鼻喷雾剂，专门用于阿片类药物过量的紧急救治。\n这一批准标志着在应对阿片类药物危机、提高急救药物可及性方面迈出了重要一步。纳洛酮是一种能够快速逆转阿片类药物过量效应的药物，此前通常需要处方才能获得。Rextovy作为非处方药上市，将使得公众更易在药店等渠道直接购得，为紧急情况下的及时干预提供了便利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMPH","BK4585","BK4588","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517149430","title":"Amphastar Pharmaceuticals, Inc.2024财年实现净利润1.60亿美元，同比增加15.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517149430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517149430?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363258,"startTime":"0","endTime":"0","summary":"3月8日，Amphastar Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为1.60亿美元，同比增加15.94%；其中营业收入为7.32亿美元，同比增加13.66%，每股基本收益为3.29美元。从资产负债表来看，Amphastar Pharmaceuticals, Inc.总负债8.92亿美元，其中短期债务7.04百万美元，资产负债比为1.83，流动比率为3.07。机构评级：截至2025年3月8日，当前有5家机构对Amphastar Pharmaceuticals, Inc.目标价做出预测，其中目标均价为39.80美元，其中最低目标价为36.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000250a2647fca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000250a2647fca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516657112","title":"Amphastar Pharmaceuticals, Inc.盘中异动 下午盘大幅跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516657112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516657112?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:04","pubTimestamp":1741028653,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时04分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.06%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为1.04%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304030413abe67f78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304030413abe67f78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4557","AMPH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320118","title":"Amphastar Pharmaceuticals, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320118?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:37","pubTimestamp":1740753470,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时37分，Amphastar Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.02%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.18%。其相关个股中，Organogenesis Holdings Inc.、百利高、Ani Pharmaceuticals, Inc.涨幅较大，Organogenesis Holdings Inc.、大自然药业、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为3.94%、2.57%、2.29%，振幅较大的相关个股有Organogenesis Holdings Inc.、Talphera, Inc.、Evoke Pharma, Inc.，振幅分别为46.58%、8.63%、7.47%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822375198967b76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822375198967b76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","AMPH","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188065952","title":"异动解读 | Amphastar Pharmaceuticals发布2024年第四季度业绩不佳,盘后股价大跌10.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188065952","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188065952?lang=zh_cn&edition=full","pubTime":"2025-02-28 06:06","pubTimestamp":1740693993,"startTime":"0","endTime":"0","summary":"Amphastar Pharmaceuticals公司(纳斯达克代码:AMPH)2024年第四季度财报业绩不佳,触发其在盘后交易中大幅下跌10.19%。\n\n根据公司公布的最新财报,Amphastar 2024年第四季度调整后每股收益为0.92美元,低于分析师预期的0.94美元。季度销售额达1.865亿美元,也未能达到预期的1.888亿美元目标。\n\n公司每股收益和营收均未达预期,引发市场对其盈利能力和增长前景的质疑。分析人士指出,该公司可能面临来自仿制药竞争加剧、新药研发进展缓慢、或营运成本过高等挑战。投资者对Amphastar的长期发展潜力失去信心,从而导致股价在盘后交易中大幅下挫。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157836861","title":"Amphastar制药2024年第四季度调整后每股收益为0.92美元,低于预期的0.94美元，销售额为1.865亿美元，未达到预期的1.888亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157836861","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157836861?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:18","pubTimestamp":1740691127,"startTime":"0","endTime":"0","summary":"Amphastar制药报告其季度每股收益为0.92美元，低于分析师预期的0.94美元，相差2.13%。这是其上一年同期每股收益0.88美元的基础上增长了4.55%。与去年同期1.78105亿美元的销售额相比，该季度销售额增长了4.71%。以上内容来自Benzinga Earnings专栏，原文如下：Amphastar Pharma  reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.94 by 2.13 percent. This is a 4.55 percent increase over earnings of $0.88 per share from the same period last year.  The company reported quarterly sales of $186.500 million which missed the analyst consensus estimate of $188.810 mill","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amphastar制药2024年第四季度调整后每股收益为0.92美元,低于预期的0.94美元，销售额为1.865亿美元，未达到预期的1.888亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508366634","title":"Piper Sandler：下调Amphastar Pharma(AMPH.US)评级，由增持调整至中性评级, 目标价由66.00美元调整至36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508366634","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508366634?lang=zh_cn&edition=full","pubTime":"2025-02-04 17:25","pubTimestamp":1738661109,"startTime":"0","endTime":"0","summary":"Piper Sandler：下调Amphastar Pharma(AMPH.US)评级，由增持调整至中性评级, 目标价由66.00美元调整至36.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/04172547948721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508622125","title":"Amphastar Pharmaceuticals, Inc.盘中异动 快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508622125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508622125?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:05","pubTimestamp":1738602334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时05分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.02%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.32%。其相关个股中，Cbdmd, Inc.、Journey Medical Corporation、Sunshine Biopharma Inc C/Wts 涨幅较大，Inmed Pharmaceuticals Inc.、Painreform Ltd.、Cbdmd, Inc.较为活跃，换手率分别为36.91%、8.72%、6.15%，振幅较大的相关个股有Procaps Group S.A. C/Wts 29/09/2026 、Procaps Group, S.A.、Sunshine Biopharma Inc C/Wts ，振幅分别为59.33%、19.85%、17.83%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010534961712c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010534961712c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4588","BK4007","BK4585","AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503187673","title":"Amphastar Pharmaceuticals, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503187673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503187673?lang=zh_cn&edition=full","pubTime":"2025-01-16 02:12","pubTimestamp":1736964768,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日02时12分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.30%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.55%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160212489604e536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160212489604e536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4007","AMPH","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492396159","title":"Amphastar Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.04%报38.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492396159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492396159?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:40","pubTimestamp":1734554407,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时40分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.04%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为1.47%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044007a1f957ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044007a1f957ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","BK4588","BK4585","AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491307207","title":"Amphastar Pharmaceuticals, Inc.盘中异动 下午盘大幅跳水5.26%报42.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491307207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491307207?lang=zh_cn&edition=full","pubTime":"2024-12-14 03:59","pubTimestamp":1734119958,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日03时59分，Amphastar Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.26%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.17%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121403591895e985c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121403591895e985c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4588","BK4007","BK4585","AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483306184","title":"Amphastar Pharmaceuticals, Inc.2024财年第三财季实现净利润40.43百万美元，同比减少17.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483306184?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686429,"startTime":"0","endTime":"0","summary":"11月16日，Amphastar Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为40.43百万美元，同比减少17.86%；其中营业收入为1.91亿美元，同比增加5.52%，每股基本收益为0.83美元。从资产负债表来看，Amphastar Pharmaceuticals, Inc.总负债8.18亿美元，其中短期债务4.46百万美元，资产负债比为1.89，流动比率为3.44。机构评级：截至2024年11月16日，当前有4家机构对Amphastar Pharmaceuticals, Inc.目标价做出预测，其中目标均价为59.00美元，其中最低目标价为55.00美元，最高目标价为66.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000214a23b88ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000214a23b88ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165981946","title":"异动解读 | Amphastar Pharmaceuticals股价大涨 市场关注业绩增长和未来前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1165981946","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165981946?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:04","pubTimestamp":1731092672,"startTime":"0","endTime":"0","summary":"北京时间11月8日,制药公司Amphastar Pharmaceuticals股价在交易中大涨5.28%,引发市场广泛关注。公司最新财报数据显示,Amphastar Pharmaceuticals实现营业收入1.91亿美元,净利润4043万美元,每股收益0.83美元,毛利1.08亿美元,业绩表现出色。市场分析人士认为,公司业绩增长及良好的盈利能力有望持续推动股价上涨。此外,有分析指出,机构看好Amphastar Pharmaceuticals的前景。作为一家专注于仿制药和特殊用药的公司,Amphastar Pharmaceuticals在医院和紧急护理领域具有广阔的市场机会。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Amphastar Pharmaceuticals股价大涨 市场关注业绩增长和未来前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482431341","title":"Amphastar Pharmaceuticals, Inc.盘中异动 急速上涨5.10%报48.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482431341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482431341?lang=zh_cn&edition=full","pubTime":"2024-11-09 02:39","pubTimestamp":1731091180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日02时39分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.10%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为2.80%。其相关个股中，Incannex Healthcare Inc.、德纳维制药、Esperion Therapeutics, Inc.涨幅较大，Evoke Pharma, Inc.、Biofrontera Inc.、Canopy Growth Corporation较为活跃，换手率分别为18.78%、10.60%、5.65%，振幅较大的相关个股有Assertio Holdings, Inc.、Quantum Biopharma Ltd.、Aytu Biopharma, Inc.，振幅分别为23.26%、19.91%、18.26%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902394098e418c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110902394098e418c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","AMPH","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154453366","title":"异动解读 | 阿霞制药公司股价大跌逾13% 第三季度业绩未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1154453366","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154453366?lang=zh_cn&edition=full","pubTime":"2024-11-08 11:01","pubTimestamp":1731034883,"startTime":"0","endTime":"0","summary":"2024年11月7日,阿霞制药公司股价大幅下跌13.52%,引发市场关注。公司此前披露的2024财年第三季度财报显示,营收及利润均未达分析师预期,这被认为是导致股价重挫的主因。具体来看,阿霞制药第三季度调整后每股收益为0.96美元,低于分析师平均预期的0.99美元;营收同比增长5.9%至1.91亿美元,但也未达预期的1.95亿美元。值得注意的是,过去三个月内,分析师对阿霞制药未来盈利预期有所下调,平均预期下降约2.8%。阿霞制药今年迄今股价累计下跌16.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159218207","title":"异动解读 | 阿霞制药公司股价大跌逾10% 第三季度营收利润未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159218207","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159218207?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:36","pubTimestamp":1730990208,"startTime":"0","endTime":"0","summary":"阿霞制药公司11月7日早盘大跌10.22%,引发市场广泛关注。公司近期披露的2024财年第三季度财报显示,营收及利润均未达分析师预期,或是引发投资者担忧的主因。根据财报数据,阿霞公司第三季度调整后每股收益为0.96美元,低于分析师平均预期的0.99美元。营收同比增长5.9%至1.91亿美元,但也未达预期的1.95亿美元。第三季度净收入为4,043万美元。过去三个月内,分析师对阿霞公司未来盈利预期有所下调,平均预期下降约2.8%。阿霞制药今年迄今股价累计下跌16.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481186062","title":"Amphastar Pharmaceuticals, Inc.股价重挫10.64% 市值跌2.46亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481186062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481186062?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:32","pubTimestamp":1730989956,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时32分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价急速下跌10.64%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.71%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722323695bde661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722323695bde661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","AMPH","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186101343","title":"异动解读 | Amphastar Pharmaceuticals第三季度业绩疲软引发股价大跌逾10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186101343","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186101343?lang=zh_cn&edition=full","pubTime":"2024-11-07 13:12","pubTimestamp":1730956376,"startTime":"0","endTime":"0","summary":"Amphastar Pharmaceuticals公司在上交所正常交易时段内大跌10.71%,引发市场广泛关注。公司此前公布的第三季度财报显示,由于业绩疲弱未达预期,或引发了投资者担忧情绪,推动股价大跌。根据财报,该公司第三季度调整后每股收益为0.96美元,低于去年同期的1.15美元,也未达到分析师预期的0.99美元。过去三个月内,平均盈利预期下降约2.8%。不过本次财报疲软表现可能加剧市场对其成长前景的担忧,推动股价大跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Amphastar Pharmaceuticals第三季度业绩疲软引发股价大跌逾10%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMPH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amphastar.com","stockEarnings":[{"period":"1week","weight":-0.035},{"period":"1month","weight":0.1041},{"period":"3month","weight":0.2907},{"period":"6month","weight":0.2396},{"period":"1year","weight":-0.0608},{"period":"ytd","weight":-0.0534}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amphastar Pharmaceuticals, Inc.是一家加利福尼亚的公司，成立于1996年2月29日，于2004年7月和amphastar制药公司一家在特拉华成立的公司合并。公司是一家专业制药公司，主要开发，生产，销售市场上通用和专用注射和吸入产品，包括投资组合的市场进入壁垒高，通用和专利产品。大多数公司的产品用于住院或紧急护理的临床设置和主要承包通过集团采购组织和药品批发商。公司的产品主要分布在药企零售。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.032842},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.035845},{"month":3,"riseRate":0.583333,"avgChangeRate":0.033475},{"month":4,"riseRate":0.5,"avgChangeRate":0.003678},{"month":5,"riseRate":0.75,"avgChangeRate":0.050154},{"month":6,"riseRate":0.666667,"avgChangeRate":0.057545},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.005293},{"month":8,"riseRate":0.615385,"avgChangeRate":0.061076},{"month":9,"riseRate":0.230769,"avgChangeRate":-0.031253},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.011592},{"month":11,"riseRate":0.75,"avgChangeRate":0.073289},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.000354}],"exchange":"NASDAQ","name":"Amphastar Pharmaceuticals","nameEN":"Amphastar Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amphastar Pharmaceuticals(AMPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amphastar Pharmaceuticals,AMPH,Amphastar Pharmaceuticals股票,Amphastar Pharmaceuticals股票老虎,Amphastar Pharmaceuticals股票老虎国际,Amphastar Pharmaceuticals行情,Amphastar Pharmaceuticals股票行情,Amphastar Pharmaceuticals股价,Amphastar Pharmaceuticals股市,Amphastar Pharmaceuticals股票价格,Amphastar Pharmaceuticals股票交易,Amphastar Pharmaceuticals股票购买,Amphastar Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amphastar Pharmaceuticals(AMPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}